Impact of Fas/FasL in Chemotherapy Response in Epithelial Ovarian Carcinoma

计划入组 28 人 · 首次发布于 2014 年 11 月 21 日

Presurgical Language Mapping With fMRI: Comparison of BOLD and fASL Techniques

计划入组 34 人 · 首次发布于 2013 年 2 月 15 日

Faslodex Post Marketing Surveillance

计划入组 42 人 · 首次发布于 2009 年 3 月 12 日

hcc49scFv-FasL

SA-FasL+ IL-2D

SA-FasL+ IL-2D (Fascure Therapeutics)

Asunercept Shows Promise in Reducing Mortality and Accelerating Recovery in Severe COVID-19

Scinai to Acquire Pincell, Advancing Novel Antibody Treatment for Severe Skin Disorders

Kadimastem and iTolerance Seek FDA Input for Novel Type 1 Diabetes Therapy, iTOL102